Sep 2026· Journal of drug targeting (Print)· pp.
1-42
· 0 citations· 100 references
Medicine
TL;DR
This review highlights recent progress in the design and application of stimuli-responsive MSNs for cancer therapy, with particular emphasis on mechanisms of intracellular uptake, factors influencing cellular internalization, and strategies for controlled drug release.
Abstract
Premature drug release in the systemic circulation or at off-target sites remains a major challenge in conventional drug delivery systems, often resulting in reduced therapeutic efficacy and increased systemic toxicity. Nanotechnology-based delivery platforms have emerged as promising strategies to address these limitations. Among them, mesoporous silica nanoparticles (MSNs) have attracted considerable attention due to their high surface area, tunable pore size, large loading capacity, and considerable structural stability. These features enable efficient encapsulation and controlled delivery of therapeutic cargos. Recent advances in MSN engineering have focused on the development of stimuli-responsive systems capable of releasing drugs in response to specific internal or external triggers, such as pH variations, temperature, light, enzymatic activity, and redox conditions (e.g., glutathione). Such smart nanocarriers facilitate site-specific drug release while minimizing off-target effects. This review highlights recent progress in the design and application of stimuli-responsive MSNs for cancer therapy. Particular emphasis is placed on mechanisms of intracellular uptake, factors influencing cellular internalization, and strategies for controlled drug release. In addition, current insights into the biocompatibility and toxicity of MSNs are discussed to provide a comprehensive perspective on their translational potential in cancer nanomedicine.
This review discusses stimuli‐responsive MSNs from the viewpoint of molecular design and release control and examines how shape, size, pore architecture, and surface functionalization influence transport, cellular uptake, loading, and release.
M. Al-Amili, Lei Lei, Zhu Jin· Smart Molecules· 0 citations
This review examines the main classes of nanoplatforms currently explored for cancer therapy, including inorganic, polymeric, lipid-based, and hybrid organic–inorganic systems, and considers emerging directions in AI-guided nanoparticle engineerization design and natural-compound-based nanomedicines, both of which are...
C. Boncristiani, F. Baldassarre, Khadija Eddahaoui et al.· Materials· 0 citations
Background: Stimuli-responsive polymeric nanoparticles (PNPs) have emerged as smart drug delivery systems capable of releasing therapeutic agents selectively in response to physiological or external stimuli. Recent advances in polymer engineering, surface functionalization, and multi-stimuli responsiveness have expande...
Cancer remains a major global health challenge, and nanoparticle-based drug delivery systems have emerged as a promising strategy for targeted cancer therapy. However, clinical translation is still limited by an incomplete understanding of how nanoparticles navigate the tumor microenvironment (TME) throughout the deliv...
Meng-Xin Ban, Si-Fang Zhao, Zi-Yu Liu et al.· Pharmaceutics· 0 citations
Over the last few decades, carbon-based nanomaterials have attracted significant attention owing to their high surface area-to-volume ratio, tunable surface properties, greater physicochemical stability, and ease of multi-functionalization. This review comprehensively summarizes the role of carbon-based nanomaterials,...
Ipsita Som, Saheli Roy, Mukta Gan Choudhuri et al.· Journal of materials chemist...· 0 citations
The present study emphasises niosomes as versatile nanocarriers with great potential for the next generation of drug delivery and describes the major challenges that need to be overcome for further clinical and commercial translation.
Khashayar Khodaverdi, S. M. Naghib, Ghasem Takdehghan et al.· BioNanoScience· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.